Column Capital Advisors’s bluebird bio BLUE Stock Holding History

Column Capital Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.28K	Hold	21	–	–	﹤0.01%	719
2023 Q2	$1.38K	Hold	21	–	–	﹤0.01%	733
2023 Q1	$1.34K	Hold	21	–	–	﹤0.01%	748
2022 Q4	$2.91K	Hold	21	–	–	﹤0.01%	671
2022 Q3	$3K	Hold	21	–	–	﹤0.01%	588
2022 Q2	$2K	Hold	21	–	–	﹤0.01%	625
2022 Q1	$2K	Hold	21	–	–	﹤0.01%	640
2021 Q4	$4K	Sell	21 -11	-34%	-$2.6K	﹤0.01%	595
2021 Q3	$8K	Hold	32	–	–	﹤0.01%	492
2021 Q2	$13K	Hold	32	–	–	﹤0.01%	436
2021 Q1	$13K	Hold	32	–	–	﹤0.01%	422
2020 Q4	$18K	Hold	32	–	–	﹤0.01%	381
2020 Q3	$23K	Hold	32	–	–	0.01%	343
2020 Q2	$25K	Hold	32	–	–	0.01%	340
2020 Q1	$19K	Hold	32	–	–	0.01%	314
2019 Q4	$36K	Buy	+32	New	+$34.8K	0.02%	284

Other funds holding BLUE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Column Capital Advisors's BLUE Position: Q3 2023 in Review

Column Capital Advisors held its bluebird bio (BLUE) position steady in Q3 2023 at 21 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

Column Capital Advisors first reported a position in BLUE in Q4 2019 and has held it in 16 quarters since. The position peaked at $36K in Q4 2019. 168 funds tracked by Wall St. Rank hold BLUE as of Q3 2023.

Column Capital Advisors held 21 shares of bluebird bio worth $1.28K as of Q3 2023.
Column Capital Advisors left its bluebird bio share count unchanged in Q3 2023.
bluebird bio made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #719 holding.
Column Capital Advisors first reported a position in bluebird bio in Q4 2019 and has held it in 16 quarters since.
Column Capital Advisors's bluebird bio position peaked at $36K in Q4 2019.
168 funds tracked by Wall St. Rank held bluebird bio as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.